Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

BACKGROUND: Checkpoint inhibitor-induced hepatitis is an immune-related adverse event of programmed cell death protein 1 (PD-1) inhibition, cytotoxic T-lymphocyte associated 4 (CTLA-4) inhibition or the combination of both. Aim of this study was to assess whether checkpoint inhibitor-induced hepatit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatol Int
Main Authors: Biewenga, Maaike, van der Kooij, Monique K., Wouters, Michel W. J. M., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., de Groot, Jan Willem B., Boers-Sonderen, Marye J., Hospers, Geke A. P., Piersma, Djura, van Rijn, Rozemarijn S., Suijkerbuijk, Karijn P. M., ten Tije, Albert J., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Haanen, John B. A. G., van der Eertwegh, Alfons J. M., van Hoek, Bart, Kapiteijn, Ellen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer India 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8144142/
https://ncbi.nlm.nih.gov/pubmed/33634373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-021-10151-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados